Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

MYSTERIOUS: 16 - What They Never Told You

Breakthrough Antibiotic Zosurabalpin To Target Drug-Resistant Bacteria CRAB

Zosurabalpin is now undergoing human trials and is set to target CRAB which holds a priority 1 classification as a critical pathogen by the WHO.

International Business Times UK

Novel Antibiotic To Treat Drug-Resistant Bacteria? Zosurabalpin Shows Promising Results In Mice

The novel antibiotic, Zosurabalpin, shows promising results in treating highly drug-resistant strains of Carbapenem-resistant Acinetobacter baumannii (CRAB) in mouse models.

Medical Daily

Drug war: On use of antibiotics and antimicrobial resistance

Infectious diseases specialists and critical-care experts have for long been waving the red flag over antimicrobial resistance, or AMR, calling for rational prescription of antibiotics

The Hindu

From analysis to the latest developments in health,
read the most diverse news in one place.

New antibiotic zosurabalpin shows promise against drug-resistant bacteria – an expert explains how it works

Researchers have identified an entirely new class of antibiotic that can kill bacteria that are resistant to most current drugs.

The Conversation

US faces ‘tragic’ rise in syphilis cases with life-saving drug in short supply

Incidence of serious sexually transmitted disease at 27-year high and demand for preferred antibiotic is straining manufacture

The Guardian - US

Revolutionary Antibiotic Breakthrough: Tackling Deadly Drug-Resistant Bacteria!

Researchers make strides in the battle against antibiotic resistance with a potential new class of drugs to combat drug-resistant bacteria, like CRAB.

Top News

Drugs Control Administration seizes fake antibiotics worth ₹22.95 lakh

The Hindu

Read news from The Economist, FT, and more,
with one subscription

Scientists hail new antibiotic that can kill drug-resistant bacteria

Zosurabalpin has defeated strains of pneumonia and sepsis in mice, raising hopes for human trials

The Guardian - UK

55% of patients were prescribed antibiotics for preventive indications, 45% for therapeutic indications: NCDC survey

Over half of the almost 10,000 hospital patients surveyed recently were given antibiotics to prevent infection, rather than to treat it, amidst growing concerns about the rise in resistance to antibiotics.

The Hindu

Use ‘mothballed’ Covid mega lab to help tackle antibiotic resistance, MPs urge

The Rosalind Franklin Laboratory – which has received more than £1 billion of public funding – is currently on sale on Rightmove.

The Independent UK

Govt. plans to make all family health centres in Kerala antibiotic-smart this year

Kerala Health Minister announces programme to make all FHCs antibiotic-smart & discourage sale of antibiotics without prescription.

The Hindu

New algorithm dramatically cuts unnecessary antibiotic use in kids

An algorithm reduced rates of antibiotics use in kids treated at Tanzanian primary care facilities without compromising their chances of getting better.

LiveScience

‘Millions of women are suffering who don’t have to’: why it’s time to end the misery of UTIs

Urinary tract infections have been a cause of chronic distress for generations of menopausal women. Campaigning journalist Kate Muir argues the problem could be halved if an alternative treatment to antibiotics is better understood. So why isn’t more being done?

The Guardian - UK

Antimicrobial resistance now hits lower-income countries the hardest, but superbugs are a global threat we must all fight

Antimicrobial resistance (AMR) is one of the World Health Organization’s most urgent health challenges for the next decade. While AMR is a global threat, a tale of two worlds emerges, highlighting the heightened vulnerability of low- and middle-income countries (LMICs).

The Conversation

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

Analyzing the Bullish Opportunities of 3 Biotech Stocks

The biotech industry is well-positioned for solid growth due to rising demand for quality treatments and therapies, a rapidly aging population, adoption of technologies like AI and government initiatives. To leverage these trends, consider investing in quality biotech stocks Innoviva (INVA), Puma Biotechnology (PBYI), and Shionogi (SGIOY). Keep reading….

LiveScience

Vaccine for superbugs? New shot shows promise in early tests

A new vaccine, so far tested only in mice, broadly activates the immune system against a wide array of bacteria and fungi.

The Guardian - UK

Mike Brown obituary

Other lives: Academic pharmacist and pharmaceutical microbiologist who specialised in understanding how bacteria respond to antibiotics

The Conversation

Do you really need antibiotics? Curbing our use helps fight drug-resistant bacteria

Antimicrobial resistance is one of the biggest global threats to health, food security and development. This month, The Conversation’s experts explore how we got here and the potential solutions.

Get all your
news in one place.

100's of premium titles.
One news app.

Zenger

New Study Uncovers Profound Implications Of E.coli’s Antibiotic Resistance Evolution

E.coli's ability to evolve antibiotic resistance may be greater than previously thought, study reveals

Newcastle Herald

Drug resistance threat: 'don't ask doctor for antibiotics for a cold'

Deaths are occurring from antibiotics resistance in the region.

The Independent UK

Study reveals the people most likely to die from sepsis

Other groups more at risk included people who have a history of extensive antibiotic exposure and those with learning difficulties

The Conversation

Drug resistance may make common infections like thrush untreatable

Antimicrobial resistance is one of the biggest global threats to health, food security and development. This month, The Conversation’s experts explore how we got here and the potential solutions.

The Conversation

No, antibiotics aren't always needed. Here's how GPs can avoid overprescribing

Antimicrobial resistance is one of the biggest global threats to health, food security and development. This month, The Conversation’s experts explore how we got here and the potential solutions.

The Conversation

Antibiotic resistance causes more deaths than malaria and HIV/Aids combined. What Africa is doing to fight this silent epidemic

Each year antimicrobial resistance – the ability of microbes to survive agents designed to kill them – claims more lives than malaria and HIV/Aids combined. Africa bears the brunt of this development, which thrives on inequality and poverty. Nadine Dreyer asked Tom Nyirenda, a research scientist with over 27 years’…

The Conversation

Antibiotic resistance: microbiologists turn to new technologies in the hunt for solutions – podcast

The rise of drug-resistant infections is one of the biggest global threats to health, food security and development. Antibiotic-resistant superbugs were estimated to kill 1.27 million people in 2019, and the UN projects that drug-resistant diseases could cause 10 million deaths a year by 2050.

1 … 15 16 17 18

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the World Health Organization

The Conversation Weekly

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.